← All stocks

Aura Biosciences, Inc.

AURA No buying or selling
CIK 0001501796 #2744 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

17 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Holles Natalie C.
See Remarks
1,153,962
$7.41M
de los Pinos Elisabet
See Remarks
575,815
$3.70M
+75.5%
Hopkins Janet Jill
Chief Medical Officer
380,190
$2.44M
+132.5%
Gibney Anthony S
See Remarks
265,354
$1.70M
+3,040%
Plavsic Mark
Chief Technology Officer
243,736
$1.56M
+89.7%
Kilroy Conor
See Remarks
232,693
$1.49M
+142.4%
Johnson David Michael
Director
194,167
$1.25M
+32.8%
Elazzouzi Amy
SVP, Finance & PAO
143,600
$921.91K
+259.0%
Abu-Absi Susan
Chief Operating Officer
134,513
$863.57K
Feder Julie B
Chief Financial Officer
134,276
$862.05K
0.0%
Person Julie
Chief People Officer
107,611
$690.86K
Kratz Erica
Chief Reg. & Quality Officer
100,885
$647.68K
Srivastava Sapna
Director
38,500
$247.17K
+266.7%
Mattessich Antony C.
Director
38,500
$247.17K
+266.7%
Bitetti Teresa Marie
Director
36,000
$231.12K
Bender Jeremy
Director
30,000
$192.60K
Matrix Capital Management Company, LP entity
10% owner
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 2.1 over the window, from 49,951,466 to 103,704,809 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 5
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 425,399
History held since 29 Oct 2021